The announcement identifies that it is a "commercial" partnership as against a "research" partnership and given that the only commercial enterprise within cooee of Microba currently is the microbiome tests then I guess it means that Microba is looking to go big fast with the test business. Maybe one of the existing or potential distributors wants to be more than just a distributor and has convinced Microba that it can grow the business in a accretive way for both it and Microba.
Microba is only a relatively new listing on the ASX so hopefully it is not a change of control transaction. The other thing is that both the chair and the deputy chair only recently bought a bunch of MAP shares. It would be surprising if they had done so immediately before a company changing transaction.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.38M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 61774 | 9.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.5¢ | 114482 | 1 |
View Market Depth
| Last trade - 16.21pm 31/07/2025 (20 minute delay) ? |
| MAP (ASX) Chart |
Day chart unavailable